Tumor-targeted pan-RAS inhibition as a novel biologic therapy for diffuse midline glioma.
Sbergio SG, Liang H, Chen L, Canty L et al. • Neuro-oncology
(2026)
PMC
PMC Public Access (View-Only)
DOI:
10.1093/neuonc/noag148
PMC: PMC13731856